Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Guilong Guo"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Lung cancer (LC) is one of the most lethal and most prevalent malignant tumors, and lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. Breast cancer (BC) is the most common cancer worldwide, but metastases to the breast f
Externí odkaz:
https://doaj.org/article/e9a8436380ef47feb73b30b23bdc179d
Autor:
Xuanxuan Dai, Changtian Yin, Yi Zhang, Guilong Guo, Chengguang Zhao, Ouchen Wang, Youqun Xiang, Xiaohua Zhang, Guang Liang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-11 (2018)
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive subgroup of human breast cancer. Patients with TNBC have poor clinical outcome as they are non-responsive to current targeted therapies. There is an urgent need to identify new
Externí odkaz:
https://doaj.org/article/24a7cdb13f584312a8b557002c25565a
Autor:
Xuanxuan Dai, Guilong Guo, Peng Zou, Ri Cui, Weiqian Chen, Xi Chen, Changtian Yin, Wei He, Rajamanickam Vinothkumar, Fan Yang, Xiaohua Zhang, Guang Liang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background Non–small cell lung cancer (NSCLC) accounts for approximately 80–85% of all lung cancers and is usually diagnosed at an advanced stage with poor prognosis. Targeted therapy has produced unprecedented outcomes in patients with
Externí odkaz:
https://doaj.org/article/56e2deb0c1e54e70a4585a584dd004fd
Publikováno v:
Acta Biochimica et Biophysica Sinica; Apr2024, Vol. 56 Issue 4, p564-575, 12p
Autor:
Shurong Zheng, Weida Fu, Qidi Huang, Jieyu Zhou, Kangkang Lu, Junwei Gu, Ruimin Ma, Guilong Guo
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 50:431-442
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3767b7543b30e9e216748f5732606405
https://doi.org/10.1111/1440-1681.13758
https://doi.org/10.1111/1440-1681.13758
Publikováno v:
Cancer Management and Research. 14:525-534
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69dbdcc476c3ec176baef502d2c43428
https://doi.org/10.2147/cmar.s345078
https://doi.org/10.2147/cmar.s345078
Publikováno v:
Cancer Management and Research. 11:10827-10839
Purpose We aimed to construct universally applicable nomograms incorporating prognostic factors to predict the prognosis of patients with triple-negative breast cancer (TNBC). Patients and methods Clinicopathological data of 379 patients with TNBC fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10b4b91e671174a9a31e5689f2af930e
https://doi.org/10.2147/cmar.s234926
https://doi.org/10.2147/cmar.s234926
Autor:
Xiaohong Xu, Tao Yan, Jinxin He, Guang Liang, Vinothkumar Rajamanickam, Yi Wang, Zhoudi Liu, Zhiguo Liu, Guilong Guo, Sheng Shu
Publikováno v:
Drug Design, Development and Therapy. 13:3539-3550
Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer which is associated with poor patient outcome and lack of targeted therapy. Our laboratory has synthesized a series of indole-2-carboxamide derivatives. Among t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61b857f82e9305dd288ddca5fc324815
https://doi.org/10.2147/dddt.s216542
https://doi.org/10.2147/dddt.s216542
Autor:
Xiaojia Wang, Lei Lei, Peifen Fu, Ouchen Wang, Xiaohong Xie, Haibin Xu, Weiliang Feng, Hongjian Yang, Guinv Hu, Shuguang Li, Zhijun Dai, Guilong Guo, Xiaoai Lv, Ya-bing Zheng, Zhan-hong Chen, Xi-Ying Shao
Publikováno v:
Journal of Clinical Oncology. 40:e12514-e12514
e12514 Background: 28-gene signature (RecurIndex) is the first multi-gene panel for recurrence risk prediction after surgery developed from the Asian breast cancer population. In this study, we aimed to report the clinical and genomic characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13b814a46cc552d144dc910fa7f1a49d
https://doi.org/10.1200/jco.2022.40.16_suppl.e12514
https://doi.org/10.1200/jco.2022.40.16_suppl.e12514
Autor:
Xiaohong Xu, Vinothakumar Rajamanicham, Sujing Xu, Zhoudi Liu, Tao Yan, Guang Liang, Guilong Guo, Huiping Zhou, Yi Wang
Publikováno v:
Biomedicine & Pharmacotherapy. 149:112865
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a337687b736ae46bd9a6bd503b4a6cc9
https://doi.org/10.1016/j.biopha.2022.112865
https://doi.org/10.1016/j.biopha.2022.112865